PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35192143-9	2022	4-PBA treatment significantly hindered the expression of endoplasmic reticulum stress markers, such as PERK, ATF4, ATF6, p-eIF2alpha, IRE1, CHOP and XBP1, suggesting that the administration of 4-PBA was successful.	4-phenylbutyric acid	0-5	X-box binding protein 1	Homo sapiens	149-153	
35192143-9	2022	4-PBA treatment significantly hindered the expression of endoplasmic reticulum stress markers, such as PERK, ATF4, ATF6, p-eIF2alpha, IRE1, CHOP and XBP1, suggesting that the administration of 4-PBA was successful.	4-phenylbutyric acid	193-198	X-box binding protein 1	Homo sapiens	149-153	
31416082-14	2019	CSE treatment significantly increased the expression of GRP78, IRE1, XBP-1 and ATF6 at the protein level at 48 h. Pretreatment with TG enhanced, whereas pretreatment with 4-PBA inhibited, the CSE-induced expression of alpha-SMA, GRP78 and XBP-1.	4-phenylbutyric acid	171-176	X-box binding protein 1	Homo sapiens	239-244	
27373828-8	2016	Treatment with 4-PBA considerably reduced the levels of BiP, IRE1alpha, and XBP1 in GCD2 cells; notably, 4-PBA treatment significantly reduced the levels of TGFBIp without change in TGFBI mRNA levels.	4-phenylbutyric acid	15-20	X-box binding protein 1	Homo sapiens	76-80	
27373828-8	2016	Treatment with 4-PBA considerably reduced the levels of BiP, IRE1alpha, and XBP1 in GCD2 cells; notably, 4-PBA treatment significantly reduced the levels of TGFBIp without change in TGFBI mRNA levels.	4-phenylbutyric acid	105-110	X-box binding protein 1	Homo sapiens	76-80